{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-001170","form_type":"8-K","ticker":"TELO","cik":"0001971532","company_name":"Telomir Pharmaceuticals, Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.907494+00:00","generated_at":"2026-05-16T10:58:02.410546+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Telomir receives Nasdaq non-compliance notice for missing annual meeting; has until Feb 23 to submit plan","bullets":["Received Nasdaq notice on Jan 8, 2026 for failure to hold annual meeting within 12 months of fiscal year end (Rule 5620(a)).","No immediate delisting; trading continues. Must submit compliance plan by Feb 23, 2026.","Preliminary proxy filed Nov 20, 2025 still under SEC review; expects to hold meeting promptly after clearance."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-001170","json":"https://secwatch.observer/filing/0001493152-26-001170.json","markdown":"https://secwatch.observer/filing/0001493152-26-001170.md","text":"https://secwatch.observer/filing/0001493152-26-001170.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226001170/0001493152-26-001170-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226001170/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:58:02.410546+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4c94d391f7fa01f353f16c4d097693c32b90547a","claim":"Telomir Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).","evidence_excerpt":"January 8, 2026, the Company received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5620(a), which requires listed companies to hold an annual meeting of shareholders within twelve months of the end of their fiscal year. The Notice does not result in the immediate delisting of the Company’s securities and has no current effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market. Pursuant to the Notice, the Company has","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1971532/000149315226001170/0001493152-26-001170-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Rules","value":"5620(a)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}